Clinical Trials Directory

Trials / Conditions / SLE - Systemic Lupus Erythematosus

SLE - Systemic Lupus Erythematosus

12 registered clinical trials studyying SLE - Systemic Lupus Erythematosus — 12 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingAssociating Gastric Infection With Autoimmune Flare Severity in an Egyptians
NCT07157202
Assiut University—
Not Yet RecruitingIASO-782 in Systemic Lupus Erythematosus
NCT07483346
Shanghai IASO Biotechnology Co., LtdPhase 1
Enrolling By InvitationA Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chines
NCT07266090
Viatris Pharmaceuticals Co., Ltd.Phase 2
RecruitingCAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases
NCT07315087
Institute of Hematology & Blood Diseases Hospital, ChinaPhase 1
Not Yet RecruitingCD19/BCMA CAR-T for SLE
NCT07266337
Chengdu Ucello Biotechnology Co., Ltd.EARLY_Phase 1
RecruitingA Study of CC312 for Relapsed/Refractory Autoimmune Diseases
NCT07193810
CytoCares IncEARLY_Phase 1
Not Yet RecruitingOMERACT SLE Delphi
NCT07136090
University Health Network, Toronto—
RecruitingSafety and Efficacy Study of CC312 for Moderate to Severe SLE
NCT07177911
CytoCares IncPhase 1
Not Yet RecruitingThe Relation of Albumin/Globulin Ratio and Platelet/Albumin Ratio to Lupus Nephritis
NCT07130448
Assiut University—
RecruitingDoes Belimumab Modify the Natural History of SLE? A Propensity Score-matched, Real-world Study
NCT07056621
Biomedical Research Foundation, Academy of Athens—
RecruitingAllogeneic UCB-derived CAR-T for SLE
NCT07274059
Chengdu Ucello Biotechnology Co., Ltd.EARLY_Phase 1
RecruitingMB-CART19.1 in Refractory SLE
NCT06189157
Miltenyi Biomedicine GmbHPhase 1 / Phase 2